KEYCORP NEW
For the period ended Jun 30, 2024. Filed Jul 26, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Jul 26, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Capital
The objective of capital management is to maintain capital levels consistent with our risk appetite and of a sufficient amount to operate under a wide range of economic conditions. Our current capital levels position us well to execute against our capital priorities including supporting organic growth and paying dividends.
The following sections discuss certain ways we have deployed our capital. For further information, see the Consolidated Statements of Changes in Equity and Note 19 (“Shareholders' Equity”).
Dividends
Consistent with our capital plan, we paid a quarterly dividend of $.205 per Common Share for the second quarter of 2024. Further information regarding the capital planning process and CCAR is included under the heading “Capital planning and stress testing” beginning on page 16 in the “Supervision and Regulation” section of our 2023 Form 10-K.
Common shares outstanding
Our Common Shares are traded on the NYSE under the symbol KEY with 27,889 holders of record at June 30, 2024. Our book value per Common Share was $13.09 based on 943.2 million shares outstanding at June 30, 2024, compared to $13.02 per Common Share based on 936.6 million shares outstanding at December 31, 2023. At June 30, 2024, our tangible book value per Common Share was $10.13, compared to $10.02 per Common Share at December 31, 2023.
Figure 18 shows activities that caused the change in outstanding Common Shares over the past five quarters.
Figure 18. Changes in Common Shares Outstanding
| 2024 · 2023 | |||||
|---|---|---|---|---|---|
| In thousands | Second | First | Fourth | Third | Second |
| Shares outstanding at beginning of period | 942,776 | 936,564 | 936,161 | 935,733 | 935,229 |
| Shares issued under employee compensation plans (net of cancellations and returns) | 424 | 6,212 | 403 | 428 | 504 |
| Shares outstanding at end of period | 943,200 | 942,776 | 936,564 | 936,161 | 935,733 |
As shown above, Common Shares outstanding increased by 424 thousand shares during the second quarter of 2024. We did not complete any open market share repurchases in the second quarter of 2024.
At June 30, 2024, we had 313.5 million treasury shares, compared to 320.1 million treasury shares at December 31, 2023. Going forward we expect to reissue treasury shares as needed in connection with stock-based compensation awards and for other corporate purposes.
Information on repurchases of Common Shares by KeyCorp is included in Part II, Item 2. “Unregistered Sales of Equity Securities and Use of Proceeds” of this report.
Capital adequacy
Capital adequacy is an important indicator of financial stability and performance. All of our capital ratios remained in excess of regulatory requirements at June 30, 2024. Our capital and liquidity levels are intended to position us to weather an adverse operating environment while continuing to serve our clients’ needs, as well as to meet the Regulatory Capital Rules described in Item 1. Business of our 2023 Form 10-K under the heading “Supervision and Regulation.” Our shareholders’ equity to assets ratio was 7.9% and 7.8% at June 30, 2024, and December 31, 2023, respectively. Our tangible common equity to tangible assets ratio was 5.2% and 5.1% at June 30, 2024, and December 31, 2023, respectively. See the section entitled “GAAP to Non-GAAP Reconciliations,” which presents the computations of certain financial measures related to “tangible common equity.” The minimum capital and leverage ratios under the Regulatory Capital Rules together with the ratios of KeyCorp at June 30, 2024, are set forth in the “Supervision and regulation — Regulatory capital requirements” section in Part I, Item 2 of this report.
Figure 19 represents the details of our regulatory capital positions at June 30, 2024, and December 31, 2023, under the Regulatory Capital Rules. Information regarding the regulatory capital ratios of KeyCorp’s banking subsidiaries is presented annually, with the most recent information included in Note 24 (“Shareholders' Equity”) beginning on page 175 of our 2023 Form 10-K.
Figure 19. Capital Components and Risk-Weighted Assets
| Dollars in millions · June 30, 2024 · December 31, 2023 | ||||
|---|---|---|---|---|
| Key shareholders’ equity (GAAP) | $14,789 | $14,637 | ||
| Less: | Preferred Stock (a) | 2,446 | 2,446 | |
| Add: | CECL phase-in (b) | 59 | 118 | |
| Common Equity Tier 1 capital before adjustments and deductions | 12,402 | 12,309 | ||
| Less: | Goodwill, net of deferred taxes | 2,590 | 2,594 | |
| Intangible assets, net of deferred taxes | 35 | 49 | ||
| Deferred tax assets | 20 | 1 | ||
| Net unrealized gains (losses) on available-for-sale securities, net of deferred taxes | (4,256) | (4,296) | ||
| Accumulated gains (losses) on cash flow hedges, net of deferred taxes | (613) | (656) | ||
| Amounts in AOCI attributed to pension and postretirement benefit costs, net of deferred taxes | (274) | (277) | ||
| Total Common Equity Tier 1 capital | $14,900 | $14,894 | ||
| TIER 1 CAPITAL | ||||
| Common Equity Tier 1 | $14,900 | $14,894 | ||
| Additional Tier 1 capital instruments and related surplus | 2,446 | 2,446 | ||
| Less: | Deductions | — | — | |
| Total Tier 1 capital | $17,346 | $17,340 | ||
| TIER 2 CAPITAL | ||||
| Tier 2 capital instruments and related surplus | $1,766 | $2,020 | ||
| Allowance for losses on loans and liability for losses on lending-related commitments (c) | 1,757 | 1,668 | ||
| Less: | Deductions | — | — | |
| Total Tier 2 capital | 3,523 | 3,688 | ||
| Total risk-based capital | $20,869 | $21,028 | ||
| RISK-WEIGHTED ASSETS(e) | ||||
| Risk-weighted assets on balance sheet | $109,745 | $115,861 | ||
| Risk-weighted off-balance sheet exposure | 30,791 | 31,555 | ||
| Market risk-equivalent assets | 1,436 | 1,159 | ||
| Gross risk-weighted assets | 141,972 | 148,575 | ||
| Less: | Excess allowance for loan and lease losses | — | — | |
| Net risk-weighted assets | $141,972 | $148,575 | ||
| AVERAGE QUARTERLY TOTAL ASSETS | $190,549 | $191,948 | ||
| CAPITAL RATIOS(e) | ||||
| Tier 1 risk-based capital | 12.22% | 11.67% | ||
| Total risk-based capital | 14.70% | 14.15% | ||
| Leverage (d) | 9.10% | 9.03% | ||
| Common Equity Tier 1 | 10.50% | 10.02% | ||
(a)Net of capital surplus.
(b)Amount reflects our decision to adopt the CECL transitional provision.
(c)The ALLL included in Tier 2 capital is limited by regulation to 1.25% of the institution’s standardized total risk-weighted assets (excluding its standardized market risk-weighted assets). The ALLL includes $14 million and $16 million of allowance classified as “discontinued assets” on the balance sheet at June 30, 2024, and December 31, 2023, respectively.
(d)This ratio is Tier 1 capital divided by average quarterly total assets as defined by the Federal Reserve less: (i) goodwill, (ii) the disallowed intangible and deferred tax assets, and (iii) other deductions from assets for leverage capital purposes.
(e)June 30, 2024 capital ratios and risk weighted assets are estimates.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.